Complications of Psychotropic and Pain Medications in an Ultrarapid Metabolizer Patient at the Upper 1% of Cytochrome P450 (CYP450) Function Quantified by Combinatorial CYP450 Genotyping

Journal of Pain & Palliative Care Pharmacotherapy
Gualberto RuañoJonathan Kost

Abstract

A 44-year-old Caucasian woman presented with a history of empirical treatment with 20 pain and psychotropic medications, as well as dual comorbidity of intractable pain and depression. A multiple gain-of-function profile in the CYP450 family of cytochrome P450 (CYP450) drug metabolism isoenzymes was discovered. The patient was a homozygote of suprafunctional alleles for both CYP2D6 ((*)35/(*)35) and CYP2C19 ((*)17/(*)17) genes and functional alleles for CYP2C9 ((*)1/(*)1), which account for aggregate drug metabolism function at the upper 1% of the population. The patient improved clinically with discontinuation of psychotropics and pain medications that were substrates of CYP2D6 and/or CYP2C19, suggesting that much of her symptomatology was drug induced. Combinatorial genotyping of CYP450 genes is diagnostically useful in individuals with histories of multiple side effects or drug resistance, which could be avoided by genetically informed therapeutics in behavioral health.

References

Jun 1, 1997·Pharmacogenetics·R A McLellanM Ingelman-Sundberg
Aug 16, 2003·Journal of Clinical Psychopharmacology·Jose de LeonPeter Wedlund
Jun 5, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maria Gabriella ScordoEdoardo Spina
Dec 31, 2004·The New England Journal of Medicine·Yvan GascheJules Desmeules
May 27, 2005·The New England Journal of Medicine·Grant R Wilkinson
Mar 7, 2007·Clinical Pharmacology and Therapeutics·Andrew A SomogyiJanet K Coller
Jul 13, 2007·Clinical Pharmacology and Therapeutics·I RudbergE Molden
Nov 1, 2007·Clinical Pharmacology and Therapeutics·A GaedigkJ S Leeder
Feb 26, 2008·British Journal of Clinical Pharmacology·R Michael BaldwinLeif Bertilsson
Mar 18, 2010·British Journal of Clinical Pharmacology·Alain Li-Wan-PoJames Lithgow
Sep 9, 2011·Journal of the American Academy of Nurse Practitioners·Joan LandinoGualberto Ruaño
Feb 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·Joseph McGraw, Donald Waller
Mar 15, 2013·Clinical Pharmacology and Therapeutics·J K HicksUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jan 25, 2014·Clinical Pharmacology and Therapeutics·K R CrewsUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jun 10, 2014·Clinical Biochemistry·Bhushan M KapurJulie L V Shaw
Mar 25, 2015·The Clinical Journal of Pain·Renee C B ManworrenGualberto Ruaño
May 15, 2015·Clinical Pharmacology and Therapeutics·J K HicksUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Feb 26, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Gualberto RuañoJohn W Goethe
Jul 22, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Kelly E CaudleJames M Hoffman

❮ Previous
Next ❯

Citations

Sep 24, 2020·Journal of the American College of Clinical Pharmacy : JAACP·Idaliz Rodríguez-EscuderoJorge Duconge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.